From molecules to medicines: the dawn of targeted therapies for genetic epilepsies.

Saved in:
Bibliographic Details
Title: From molecules to medicines: the dawn of targeted therapies for genetic epilepsies.
Authors: Demarest ST; Departments of Pediatrics and Neurology, University of Colorado School of Medicine, Aurora, CO, USA. scott.demarest@ucdenver.edu.; Department of Pediatric Neurology and Neuroscience Institute, Children's Hospital Colorado, Aurora, CO, USA. scott.demarest@ucdenver.edu., Brooks-Kayal A; Departments of Pediatrics and Neurology, University of Colorado School of Medicine, Aurora, CO, USA.; Department of Pediatric Neurology and Neuroscience Institute, Children's Hospital Colorado, Aurora, CO, USA.
Source: Nature reviews. Neurology [Nat Rev Neurol] 2018 Dec; Vol. 14 (12), pp. 735-745.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500072 Publication Model: Print Cited Medium: Internet ISSN: 1759-4766 (Electronic) Linking ISSN: 17594758 NLM ISO Abbreviation: Nat Rev Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-4766
DOI:10.1038/s41582-018-0099-3